Article
A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study.
PloS one - 1 Jan 2020
Semmo Nasser, Müllhaupt Beat, Ruckstuhl Lisa, Magenta Lorenzo, Clerc Olivier, Torgler Ralph, Semela David
Abstract excerpt
AIM: Fatigue is the most commonly reported symptom of Hepatitis C Virus (HCV) infected patients and severely impacts their quality of life. The aim of this study was to measure the impact of 3D regimen treatment on the fatigue, daytime physical activity and sleep efficiency of HCV infected patients with fatigue. METHODS: HEMATITE was an observational, prospective, open-label, single-arm, Swiss multi-centric study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.